Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 317Squamous Cell Carcinoma of Head and Neck 168Head and Neck Neoplasms 150Carcinoma, Non-Small-Cell Lung 97Colonic Neoplasms 90Rectal Neoplasms 82Neoplasm Metastasis 72Neoplasms 60Pancreatic Neoplasms 40Carcinoma, Squamous Cell 40Lung Neoplasms 35Esophageal Neoplasms 25Breast Neoplasms 22Stomach Neoplasms 20Recurrence 20Carcinoma 18Laryngeal Neoplasms 17Tongue Neoplasms 16Mouth Neoplasms 16Oropharyngeal Neoplasms 14Esophageal Squamous Cell Carcinoma 14Salivary Gland Neoplasms 12Adenocarcinoma Of Esophagus 12Hypopharyngeal Neoplasms 11Colorectal Cancer Metastatic 11Laryngeal Diseases 10Adenocarcinoma of Lung 10Uterine Cervical Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 9Ovarian Neoplasms 9

Interventions

Irinotecan 4Oxaliplatin 3Bevacizumab 3trimebutine 3-thiocarbamoylbenzenesulfonate 2pembrolizumab 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Cetuximab 2Capecitabine 2Aspirin 2Ascorbic Acid 2repotrectinib 1pralsetinib 1napabucasin 1ibrutinib 1guadecitabine 1encorafenib 1alectinib 1XELOX 1Sutures 1Surgical Instruments 1Polyethylene Glycols 1Optical Imaging 1Ocoxin 1Levoleucovorin 1KRN-330 1Diagnosis 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Diseases × Cetuximab × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT01294826 2015-06-08

Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Swedish Medical Center

Phase 1 Completed
20 enrolled
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡